Sands Capital acquired 1.36 Million Repligen shares worth $174 Million. That's 0.52% of their equity portfolio (36th largest holding). The investor owns 2.19% of the outstanding Repligen stock. Sands Capital started to build up the position in Repligen in Q3 2022 and continued to invest until Q4 2022. Since then they sold 417 Thousand shares. The investor's estimated purchase price is $284 Million, resulting in a loss of 39%.
Conestoga Capital Advisors, an asset management company, released its “SMid Cap Growth Strategy” third-quarter 2023 investor letter. A copy of the same can b...
https://www.investing.com/news/pro/repligen-corp-receives-investment-bank-analyst-rating-update-3120648
Pulled from Benzinga Pro data, Repligen (NASDAQ: RGEN ) posted Q1 earnings of $28.83 million, an increase from Q4 of 40.84%. Sales dropped to $182.66 million...
https://www.investing.com/news/pro/rbc-capital-starts-repligen-at-sector-perform-432SI-2958584